Winton Group’s Tricida, Inc. Common Stock TCDA Stock Holding History

Winton Group’s Portfolio TCDA Stock Details TCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,213	Closed	-$247K	–	1631
2020 Q1	$247K	Buy	+11,213	New	+$360K	0.01%	1211

Other funds holding TCDA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Winton Group's TCDA Position: Q2 2020 in Review

Winton Group sold out of Tricida, Inc. Common Stock (TCDA) in Q2 2020, closing a stake of 11,213 shares — an estimated $247K sold.

Winton Group first reported a position in TCDA in Q1 2020 and held it in 1 quarter. The position peaked at $247K in Q1 2020. 114 funds tracked by Wall St. Rank hold TCDA as of Q2 2020.

Winton Group reported no remaining Tricida, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Winton Group sold 11,213 Tricida, Inc. Common Stock shares in Q2 2020, an estimated $247K.
Winton Group first reported a position in Tricida, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Winton Group's Tricida, Inc. Common Stock position peaked at $247K in Q1 2020.
114 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q2 2020.

Based on Winton Group's 13F filing for Q2 2020, filed 5 Aug 2020.